Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 3:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 2,213 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reduced Activity Clear all

Conditions: Insulin Resistance, Obesity
Interventions: INCB13739; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 2
States / cities: Beverly Hills, California • Chula Vista, California

Conditions: Obesity
Interventions: Craving and Lifestyle Management through Mindfulness(CALMM+); Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hepatitis, Viral, Human, HIV Infections
Interventions: Testing, Education, & Counseling (TEC), Hepatitis Care Coordination (HCC); Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: San Francisco, California • New York, New York

Conditions: Crohn's Disease
Interventions: Mirikizumab, Ustekinumab, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 15 Years to 80 Years
Enrollment: 1,158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 140
States / cities: Birmingham, Alabama • Dothan, Alabama • Guntersville, Alabama + 113 more

Conditions: Autism Spectrum Disorder
Interventions: Mindfulness Based Stress Reduction, Relaxation Group; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Home-Based Parenting Program, Clinic-Based Parenting Program, Wait-List Control Group; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 3 Years to 4 Years
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Ptsd
Interventions: Mindfulness-Based Stress Reduction (MBSR), Health and Wellness Education (HWE); Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Quality of Life
Interventions: CAPABLE, Attention visits; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alcohol Use
Interventions: Counseling, mHealth; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 35 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Coral Gables, Florida • Gainesville, Florida

Conditions: Amputation
Interventions: semi flexible socket, rigid fiber socket; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Adolescent Substance Use
Interventions: Guiding Good Choices; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 11 Years to 12 Years
Enrollment: 3,636 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 3
States / cities: Oakland, California • Aurora, Colorado • Detroit, Michigan

Conditions: Insulin Resistance, Sarcopenia
Interventions: Exercise, Energy Restriction-Induced Weight Loss; Behavioral
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 65 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2025
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Autism
Interventions: Aripiprazole, Placebos; Drug
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 5 Years to 17 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute, Leukemia, Myeloid, Acute, Acute Myelogenous Leukemia, Leukemia, Acute Myelogenous, Myelogenous Leukemia, Acute, AML, Bone Marrow Transplant
Interventions: Iomab-B, Conventional Care, HCT; Drug · Procedure
Lead sponsor: Actinium Pharmaceuticals; Industry
Eligibility: 55 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 22
States / cities: Gilbert, Arizona • New Haven, Connecticut • Washington D.C., District of Columbia + 18 more

Conditions: Post-Traumatic Stress Disorder
Interventions: Placebo, Vortioxetine; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Miami, Florida • Atlanta, Georgia

Conditions: Habitual Physical Activity, Sedentary Time
Interventions: exercise training, sedentary time reduction, exercsie training plus sedentary time reduction; Behavioral
Lead sponsor: University of Massachusetts, Amherst; Other
Eligibility: 20 Years to 60 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Amherst, Massachusetts

Conditions: Macular Degeneration, Choroidal Neovascularization
Interventions: Verteporfin Photodynamic Therapy, Ranibizumab, Verteporfin Placebo, Ranibizumab Placebo; Drug
Lead sponsor: Novartis; Industry
Eligibility: 50 Years and older
Enrollment: 321 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 36
States / cities: Tucson, Arizona • Beverly Hills, California • Oakland, California + 33 more

Conditions: Type 2 Diabetes
Interventions: GEM Intervention; Behavioral
Lead sponsor: Catherine Davis; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Hiv, Alcohol Problem
Interventions: Alcohol Brief Intervention (BI), Common Elements Treatment Approach (CETA) via Telemedicine; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 99 Years
Enrollment: 308 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Hip-related Groin Pain, Femoroacetabular Impingement, Dysplasia Mild, Prearthritic Hip Disorder
Interventions: Movement Pattern Training, Manual Therapy; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 40 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: ADHD
Interventions: VR Treatment, VR Active Control; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 8 Years to 12 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Wet Macular Degeneration
Interventions: Aflibercept Ophthalmic, optovue angiovue; Drug · Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 50 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chronic Insomnia, Primary Insomnia
Interventions: Mindfulness-Based Stress Reduction, eszopiclone; Behavioral · Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Minneapolis, Minnesota

Conditions: Persistent Postsurgical Pain, Breast Cancer Female, Ductal Carcinoma in Situ
Interventions: Acceptance and Commitment Therapy; Behavioral
Lead sponsor: Katherine Hadlandsmyth; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes

Craving and Lifestyle Management Through Mindfulness Pilot Study

HIV and Hepatitis Care Coordination in Methadone Treatment

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Mindfulness-Associated Brain Changes in Adults With Autism

Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers

Feasibility and Acceptability of Stress Induction, Physiological Data Collection, and Mindfulness-Based Stress Reduction Among Combat Veterans With PTSD

Reducing Disability Via a Bundled Bio-Behavioral-Environmental Approach

The Less is More Study

Reduction of Shear Forces Using Semi-flexible Sockets on Transtibial Amputees

Guiding Good Choices for Health

Muscle Insulin Resistance in Aging (Mirage)

Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children

Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

Vortioxetine for Posttraumatic Stress Disorder

Changes in Habitual Physical Activity and Inactivity

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Glycemic Excursion Minimization (GEM) to Outshine Health Disparities

Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA

Comparison of Movement Pattern Training and Manual Therapy for Prearthritic Hip Disorders

Virtual Reality Attention Management

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study

Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy